genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • DNA

      Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration

      Cosmetics
      Industry News

      Cosmetics Get Sustainability Boost From L’Oreal and Geno

      Drug Discovery

      Common Genetic Signature May Increase Risk of Multiple Substance Abuse Disorders

      Neutrophil white blood cells, illustration
      Pancreatic Cancer

      Neutrophils Found to Be Culprits in Treatment-Resistant Pancreatic Cancer

      Bioprocessing

      BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for…

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Tobacco Plantation
      AgBio

      Plants to Play Larger Role in Battle against COVID-19

      Bioprocessing

      Merck Biomanufacturing Optimization Sees Major Production Gains

      Bioprocessing

      Pharmaceutical Manufacturers Need to Stay Focused on Supply Chain Audit

      Bioprocessing

      Cell-Free Synthesis of Peptidomimetic Drugs by International Research Team

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Cancer Pancreatic Cancer

Pancreatic Cancer

  • Anal Cancer
  • Bladder Cancer
  • Bone Marrow Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer Associated Pain
  • Cervical Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Head and Neck Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Mesothelioma
  • Multiple Myeloma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Sarcoma
  • Skin Cancer
  • Stomach Cancer
    Random
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Pancreatic Cancer

    Pfizer Halts Phase III Trial with Pancreatic Cancer Drug

    Pancreatic Cancer

    Inadequate Vasculature Blamed for Pancreatic Cancer’s Resistance to Chemotherapy

    Pancreatic Cancer

    Pfizer Sees First Success in Label-Expanding Trials with Cancer Drug

    Pancreatic Cancer

    Scientists Implicate Prion Protein in Aggressive Pancreatic Cancer

    Pancreatic Cancer

    Inhibiting TAK-1 Renders Pancreatic Cancer Susceptible to Chemotherapy

    Pancreatic Cancer

    Phase II Failure Forces SciClone to Eliminate 17% of Staff

    Pancreatic Cancer

    Scientists Identify Pathway that Helps Pancreatic Cancer Surpass Chemotherapy

    Pancreatic Cancer

    Asuragen Allies with Clinical Centers to Validate miRNA Pancreatic Cancer Test

    Pancreatic Cancer

    Histone Modifications Used as Predictive Biomarkers in Pancreatic Cancer

    Pancreatic Cancer

    Ventana to Work on Companion Diagnostic for Clovis’ Phase II Lipid-Conjugated...

    Pancreatic Cancer

    Phase III Data Shows Novartis’ Afinitor More Than Doubles PFS in...

    Firms unable to agree to new financial terms following PathFinderTG reimbursement issues.[zwolafasola-Fotolia.com]
    Pancreatic Cancer

    ExonHit Backs Out of $22.5M Agreement to Acquire RedPath Integrated Pathology

    Pancreatic Cancer

    London Genetics and Astrimmune to Find Predictive Biomarkers for Pancreatic Cancer...

    Pancreatic Cancer

    Pfizer Scores New Approval for Sutent in Europe

    Molecular test detects mutations in PALB2 and BRCA2
    Pancreatic Cancer

    Myriad Genetics Releases Panexia for the Prediction of Hereditary Pancreatic Cancers

    123...17Page 1 of 17

    Recently Featured

    Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration

    Moderna, Generation Bio Launch Up-to-$1.9B Non-Viral Genetic Medicines Collaboration

    Cosmetics Get Sustainability Boost From L’Oreal and Geno

    Cosmetics Get Sustainability Boost From L’Oreal and Geno

    Neutrophils Found to Be Culprits in Treatment-Resistant Pancreatic Cancer

    Neutrophils Found to Be Culprits in Treatment-Resistant Pancreatic Cancer

    BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for Diabetes

    BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for Diabetes

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up